MyRNA Diagnostics is establishing Malaysia’s leading miRNA-based early cancer detection platform — localising globally validated technology to improve survival through earlier intervention.
A blood-based miRNA molecular screening test designed to identify individuals at elevated risk of gastric cancer and support earlier clinical intervention.
Learn More
A blood-based miRNA risk stratification test designed to identify individuals at increased risk of lung cancer and support earlier detection strategies.
Learn MoreWe collaborate with leading organizations to deliver exceptional solutions.
Stay informed with our latest articles, insights, and news.
MyRNA participated as a Gold Sponsor at the Selangor International Care Expo (SICE) 2026, held from 15–17 October 2026 at the Kuala Lumpur Convention...
On 7 September 2026, MyRNA joined leaders from academia, industry, healthcare, investment and the broader life sciences ecosystem at Monash University...
On 27 September 2026, MyRNA participated in Selangor Saring with its partner, Selcare, at Jelajah Wanita Berdaya Tahan Selangor 2026: Zon Gombak, brin...
Let's discuss how we can help you achieve your goals with our innovative solutions.
Enquire About Partnership